Angiotech Completes Sub Sale to Roundtable's Argon
Canadian specialty pharmaceuticals and medical device company Angiotech Pharmaceuticals Inc. has completed the sale of its interventional products business unit to Argon Medical Devices Inc. The divestiture, which received the approval of company shareholders on April 8th, has been estimated to value C$363 million. Plano, Texas-based Argon has been a portfolio company of U.S. private equity firm RoundTable Healthcare Partners since 2003.
15 April 2013•5 mins read
